CAPNIA, Inc. Reports Third Quarter 2016 Financial Results

REDWOOD CITY, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced financial results for the third quarter ended September 30, 2016.

“We continue to see significant interest from hospitals in the US and other countries for the installation of our CoSense ETCO monitor, and we believe the developing installed base will drive future revenue growth,” said Anish Bhatnagar, M.D., Chief Executive Officer of Capnia. “Also, consumer feedback from our pilot launch of Serenz® Allergy Relief in the United Kingdom continues to be strong, and we are working on a full commercial launch of the product. We have established a solid foundation, and look forward to a fruitful 2017.”

Back to news